Pilar Acedo
Pilar Acedo
Research Associate at University College London (UCL)
Verified email at ucl.ac.uk
TitleCited byYear
Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy
R Mejías, S Pérez-Yagüe, L Gutiérrez, LI Cabrera, R Spada, P Acedo, ...
Biomaterials 32 (11), 2938-2952, 2011
1222011
Efficient and safe internalization of magnetic iron oxide nanoparticles: two fundamental requirements for biomedical applications
M Calero, L Gutiérrez, G Salas, Y Luengo, A Lázaro, P Acedo, ...
Nanomedicine: Nanotechnology, Biology and Medicine 10 (4), 733-743, 2014
882014
Two combined photosensitizers: a goal for more effective photodynamic therapy of cancer
P Acedo, JC Stockert, M Cañete, A Villanueva
Cell death & disease 5 (3), e1122, 2014
772014
Cell death causes relocalization of photosensitizing fluorescent probes
M Alvarez, Á Villanueva, P Acedo, M Cañete, JC Stockert
Acta histochemica 113 (3), 363-368, 2011
362011
Mitotic catastrophe induced in HeLa cells by photodynamic treatment with Zn (II)-phthalocyanine
S Rello-Varona, JC Stockert, M Cañete, P Acedo, Á Villanueva
International journal of oncology 32 (6), 1189-1196, 2008
362008
JNK–NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress
A Kostecka, A Sznarkowska, K Meller, P Acedo, Y Shi, HAM Sakil, ...
Cell death & disease 5 (10), e1484, 2014
242014
A new protocol in photodynamic therapy: enhanced tumour cell death by combining two different photosensitizers
A Villanueva, JC Stockert, M Cañete, P Acedo
Photochemical & Photobiological Sciences 9 (3), 295-297, 2010
242010
Poly (D, L-lactide-co-glycolide) nanoparticles as delivery agents for photodynamic therapy: enhancing singlet oxygen release and photototoxicity by surface PEG coating
E Boix-Garriga, P Acedo, A Casadó, A Villanueva, JC Stockert, M Cañete, ...
Nanotechnology 26 (36), 365104, 2015
202015
Efficient induction of apoptosis in HeLa cells by a novel cationic porphycene photosensitizer
R Ruiz-González, P Acedo, D Sánchez-García, S Nonell, M Cañete, ...
European journal of medicinal chemistry 63, 401-414, 2013
202013
p53 family members–important messengers in cell death signaling in photodynamic therapy of cancer?
P Acedo, J Zawacka-Pankau
Photochemical & Photobiological Sciences 14 (8), 1390-1396, 2015
172015
Improved selectivity and cytotoxic effects of irinotecan via liposomal delivery: A comparative study on Hs68 and HeLa cells
A Casadó, M Mora, ML Sagristá, S Rello-Varona, P Acedo, JC Stockert, ...
European Journal of Pharmaceutical Sciences 109, 65-77, 2017
62017
Why not introducing the third dimension in photodynamic therapy research?
M Alemany-Ribes, M García-Díaz, P Acedo, M Agut, S Nonell, ...
J. Anal. Bioanal. Tech. S 1, 004, 2013
52013
Multimodal use of the porphyrin TMPyP: From cancer therapy to antimicrobial applications
IMPA Andres Garcia-Sampedro, Andrea Tabero
Journal of Porphyrins and Phthalocyanines, 2019
32019
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP 53-deficient cancer cells
A Sznarkowska, A Kostecka, A Kawiak, P Acedo, M Lion, A Inga, ...
Cell division 13 (1), 10, 2018
32018
Silica-based nanostructured materials for biomedical applications
A Gallardo, J Morales, J Comas-Barceló, T Gallavardin, P Acedo, ...
Applications of Nanoscience in Photomedicine, 429-448, 2015
32015
Protoporphyrin IX is a dual inhibitor of p53/MDM2 and p53/MDM4 interactions and induces apoptosis in B-cell chronic lymphocytic leukemia cells
L Jiang, N Malik, P Acedo, J Zawacka-Pankau
Cell death discovery 5 (1), 77, 2019
12019
Synergistic effect on antiproliferative and apoptotic activity by combining two different photosensitizers: in vitro and in vivo studies
A Villanueva, P Acedo, JC Stockert, M Canete, M Camerin, G Jori
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 32, S62-S62, 2013
12013
Correction to: Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP 53-deficient cancer cells
A Sznarkowska, A Kostecka, A Kawiak, P Acedo, M Lion, A Inga, ...
Cell Division 14 (1), 1-3, 2019
2019
Targeting Pyruvate Kinase M2 and Lactate Dehydrogenase A Is an Effective Combination Strategy for the Treatment of Pancreatic Cancer
GH Mohammad, V Vassileva, P Acedo, SWM Olde Damink, M Malago, ...
Cancers 11 (9), 1372, 2019
2019
Reactivation of TAp73 tumor suppressor by protoporphyrin IX, a metabolite of aminolevulinic acid, induces apoptosis in TP53-deficient cancer cells (vol 13, 10, 2018)
A Sznarkowska, A Kostecka, A Kawiak, P Acedo, M Lion, A Inga, ...
CELL DIVISION 14 (1), 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20